Judge Helps Define Corporate Citizenship in Pharma Suit

, The Legal Intelligencer


Finding the pulse of McNeil pharmaceuticals within the corporate structure of Johnson & Johnson required a federal judge to look beyond the U.S. Supreme Court's "nerve center" test in order to fulfill the high court's directive that corporate citizenship should be determined by where its principal place of business is located, rather than where it declares that place to be.

This content has been archived. It is available exclusively through our partner LexisNexis®.

To view this content, please continue to LexisAdvance®.

Continue to LexisAdvance®

Not a LexisAdvance® Subscriber? Subscribe Now

Why am I seeing this?

LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via LexisAdvance®. This includes content from the National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at customercare@alm.com

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article #1352064194930

Thank you!

This article's comments will be reviewed.